This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Lynch syndrome [7 genes]
Lynch syndrome is caused by mutations in one of the mismatch repair (MMR) genes, mainly in MLH1, MSH2, MSH6, PMS2, and EPCAM. This syndrome predisposes towards different types of cancer, mainly colorectal (CRC) and uterine. The risk of suffering CRC during a person’s lifetime varies between 10% and 80%, depending on the gene which is altered.
Request study
Informed consent
Steps to follow
Ask for information
Steps to follow
How to order
1. Download & fill out
Please cover as many fields as possible in both documents
2. Sample collection
Three sample types: saliva, peripheral blood or genomic DNA
3. Pack the sample
Please pack the sample in a way to prevent leakage
4. Send the sample & the request
Please schedule the delivery for Mon–Thur: 8am – 5pm
5. Result: the report
Via: Client Site HIC / Client Site Imegen / Certified email
Solicita información de
Lynch syndrome
Turnaround time (TAT): 4 weeks
Ref. S-202009672
Lynch syndrome: View panel
- EPCAM
- MLH1
- MLH3
- MSH2
- MSH3
- MSH6
- PMS2
Priority Genes : Genes where there is sufficient evidence (clinical and functional) to consider them associated with the disease; they are included in the clinical practice guidelines.
Secondary Genes: Genes related to the disease, but with a lower level of evidence or that constitute sporadic cases.
* Candidate Genes: Not enough evidence in humans, but potentially associated with the disease.